跳至主要内容
临床试验/NCT07221409
NCT07221409招募中不适用

Pilot Study to Assess Safety, Tolerability and Efficacy of Virtual Reality in Cancer Patients

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2025年10月8日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
Mayo Clinic
入组人数
24
试验地点
1
主要终点
Successfully complete the virtual reality (VR) intervention (Feasibility)

研究概览

简要总结

This clinical trial tests the safety, tolerability, and effectiveness of a virtual reality intervention to improve psychological symptom burden for cancer patients undergoing treatment. Virtual reality (VR) is a technology that allows users to experience and interact with three-dimensional, computer-generated environments that simulate the real world or imagined settings. The VR intervention consists of a preloaded with immersive environments designed to engage the senses through simulated sights and sounds. This may include a walk through of a serene forest, exploring vibrant coral reefs, swimming with dolphins, or standing at the base of a majestic waterfall. These environments are created to provide a relaxing and engaging experience. Completing the VR intervention may be a safe and effective way to improve quality of life, reduce anxiety, enhance focus, and promote healthy living for cancer patients undergoing treatment.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •History of cancer
  • •Age between 18 to 90 years
  • •Undergoing in-patient chemotherapy, bone marrow transplant (BMT), chimeric antigen receptor (CAR)-t, & out-patient chemotherapy

排除标准

  • •History of bipolar disorder, major depression, bipolar disorder, anxiety disorder, post traumatic stress disorder (PTSD), obsessive compulsive disorder (OCD), psychotic disorder, schizophrenia, personality disorder, substance use disorder other than caffeine or tobacco. History of suicidal ideation or attempt
  • •History of treatment resistant depression, psychiatric hospitalization, syncope, transient ischemic attack (TIA), stroke, epilepsy, electroconvulsive therapy, benign positional vertigo, Meniere's disease

研究组 & 干预措施

Virtual Reality (VR) Headset Intervention

Experimental

Participants will undergo a single VR session to assess feasibility, tolerability, and changes in anxiety, depression, and fatigue.

干预措施: Questionnaire Administration (Other)

Virtual Reality (VR) Headset Intervention

Experimental

Participants will undergo a single VR session to assess feasibility, tolerability, and changes in anxiety, depression, and fatigue.

干预措施: Virtual Reality (VR) Intervention (Other)

结局指标

主要结局

Successfully complete the virtual reality (VR) intervention (Feasibility)

时间窗: Baseline

Feasibility of VR will be assessed by the proportion of participants who successfully complete the intervention.

Absence of major issues during administration (Feasibility)

时间窗: Baseline

Feasibility of VR will be evaluated by the absence of (low/no recorded incidence of) major technical or usability issues during administration

Acceptability

时间窗: Baseline

Will be assessed via the Post-Study Exit Interview Questionnaire, a questionnaire developed specifically for this study. It consists of 17 questions. Eight questions relate to the VR experience (e.g., comfort of headset, control of actions in VR environment, understandability of instructions, technical issues). Five questions relate to symptoms (e.g., dizziness, nausea, headache) or discomfort experienced during and immediately following VR use. The remaining questions relate to helpfulness of intervention, improvement suggestions, other feedback, and interest in learning more about services and resources. Results will be analyzed descriptively.

Successfully complete the virtual reality (VR) intervention (Feasibility)

时间窗: Baseline

Feasibility of VR will be assessed by the proportion of participants who successfully complete the intervention.

Absence of major issues during administration (Feasibility)

时间窗: Baseline

Feasibility of VR will be evaluated by the absence of (low/no recorded incidence of) major technical or usability issues during administration

Acceptability

时间窗: Baseline

Will be assessed via the Post-Study Exit Interview Questionnaire, a questionnaire developed specifically for this study. It consists of 17 questions. Eight questions relate to the VR experience (e.g., comfort of headset, control of actions in VR environment, understandability of instructions, technical issues). Five questions relate to symptoms (e.g., dizziness, nausea, headache) or discomfort experienced during and immediately following VR use. The remaining questions relate to helpfulness of intervention, improvement suggestions, other feedback, and interest in learning more about services and resources. Results will be analyzed descriptively.

次要结局

  • Change in anxiety(Baseline (pre- to post-intervention, approximately 1.5 hours))
  • Change in depression(Baseline (pre- to post-intervention, approximately 1.5 hours))
  • Change in fatigue(Baseline (pre- to post-intervention, approximately 1.5 hours))
  • Change in overall quality of life(Baseline (pre- to post-intervention, approximately 1.5 hours))

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验